Status:
COMPLETED
Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC)
Lead Sponsor:
University Hospital, Limoges
Conditions:
Non-Small Cell Lung Cancer
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Bone-marrow-derived progenitor cells (EPCS) play an important role in neovascularization and tumor growth. In lung cancer, angiogenesis is an important event in mechanisms of tumor proliferation and m...
Detailed Description
The aim of this study is to study blood circulating levels bone-marrow-derived progenitor cells (EPCS). In a first phase, EPCs will be detected in healthy non-smokers volunteers to validate flow cyto...
Eligibility Criteria
Inclusion
- Signed written consent
- Subject \> 18 year old
- No precedent therapy for cancer
- Non-smoker healthy subject or current smoker COPD patients or NSCLC patients
Exclusion
- Small-cell lung cancer patient
- Radiotherapy, chemotherapy or target therapy for NSCLC
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00826683
Start Date
March 1 2009
End Date
January 1 2011
Last Update
August 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU limoges
Limoges, Limoges, France, 87042